Nektar Therapeutics
Nektar Therapeutics (NKTR) — Form 144: Proposed sale of shares
About this filing
Nektar Therapeutics (NKTR) filed Form 144 (proposed sale of shares) with the SEC on Nov 17, 2026. Form 144 is notice that an insider or affiliate plans to sell shares.
Key facts
- Seller
- Zalevsky Jonathan
- Relationship
- Officer
- Shares to sell
- 192
- Market value
- $6,882.68
- Approximate sale date
- Nov 17, 2026
- Broker
- Fidelity Brokerage Services LLC
- Acquired
- Nov 13, 2026 · Restricted Stock Vesting
Remarks
- Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
More NKTR filings
- 4
Filed Nov 19, 2026
- 4
Filed Nov 19, 2026
- 144
Filed Nov 17, 2026
- 8-K
Filed Nov 13, 2026
- 10-Q
Filed Nov 12, 2026
- 8-K
Filed Nov 12, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.